Loading…

Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort

BACKGROUND Systolic blood pressure (SBP) goal for chronic kidney disease (CKD) patients is ≤140mm Hg. However, the SBP target provides no suggested lower limit, and some studies indicate that a lower SBP target may be harmful. We aimed to investigate the J-shaped relationship between SBP and clinica...

Full description

Saved in:
Bibliographic Details
Published in:American journal of hypertension 2014-11, Vol.27 (11), p.1396-1407
Main Authors: Chiang, Heng-Pin, Lee, Jia-Jung, Chiu, Yi-Wen, Tsai, Jer-Chia, Hung, Chi-Chih, Hwang, Shang-Jyh, Chen, Hung-Chun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3
cites cdi_FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3
container_end_page 1407
container_issue 11
container_start_page 1396
container_title American journal of hypertension
container_volume 27
creator Chiang, Heng-Pin
Lee, Jia-Jung
Chiu, Yi-Wen
Tsai, Jer-Chia
Hung, Chi-Chih
Hwang, Shang-Jyh
Chen, Hung-Chun
description BACKGROUND Systolic blood pressure (SBP) goal for chronic kidney disease (CKD) patients is ≤140mm Hg. However, the SBP target provides no suggested lower limit, and some studies indicate that a lower SBP target may be harmful. We aimed to investigate the J-shaped relationship between SBP and clinical outcomes in CKD patients and the factors that modify this relationship. METHODS This prospective observational study enrolled 2,144 CKD stage 3-4 patients between November 2002 and May 2009 and followed them until July 2010 or death. Patients included were also enrolled within the Integrated CKD Care Program for Delaying Dialysis in a medical center and its branch hospital. Demographic, clinical, laboratory, and disease variables at baseline and end of observation were measured. RESULTS In diabetic CKD patients, the hazard ratio (HR) at SBP 96-110mm Hg vs. 111-120mm Hg was 2.52 (95% confidence interval (CI) = 1.13-5.58) for cardiovascular outcomes and was 3.14 (95% CI = 1.16-8.49) for renal outcomes. In nondiabetic CKD patients, this J-shaped relationship was not seen. Heavy proteinuria was further found to modify the J-shaped relationship in diabetic CKD patients. The HR for renal outcomes at SBP 96-110mm Hg vs. 111-120mm Hg was 4.07 (95% CI = 1.18-13.99) in diabetic CKD patients with heavy proteinuria vs. 1.72 (95% CI = 0.13-22.5) in those without heavy proteinuria. CONCLUSIONS Diabetic CKD patients have a J-shaped relationship between SBP and cardiovascular or renal outcomes, but nondiabetic CKD patients do not. The optimal SBP range might be narrower in the diabetic CKD patients.
doi_str_mv 10.1093/ajh/hpu056
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4263936</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ajh/hpu056</oup_id><sourcerecordid>2306323897</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3</originalsourceid><addsrcrecordid>eNp9kV1rFDEUhoModlu98QdIQLwpjM13Jl4IutZWLLTQeh2SzJlOlt3JmsxU9t8b2bboTa_OxXnOe154EHpDyQdKDD9xq-Fk2M5EqmdoQY2gjWZMPkcL0hrZaKLoATosZUUIEUrRl-iACc00l2aByvWuTGkdA_6yTqnDVxlKmTNgN3b4cp5C2kDBccTXk7sFzBuBl0NOYz34EbsRdvhrLOAK4Cs3RRin8hGf3sUOxgC4z2mDHb5x8bcboTLLNKQ8vUIvercu8Pp-HqGf305vlufNxeXZ9-XniyZIwqZGhJ6ACmA8c741nhAqqfJdH4LQ3nPdtkY56ZhiQijvFaOy10JT6J02MvAj9Gmfu539BrpQ22W3ttscNy7vbHLR_r8Z42Bv050VTHHDVQ14dx-Q068ZymRXac5j7WwZJ4oz3hpdqeM9FXIqJUP_-IES-1eQrYLsXlCF3_7b6RF9MFKB93sgzdungv4Aw2eahw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2306323897</pqid></control><display><type>article</type><title>Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort</title><source>Oxford Journals Online</source><creator>Chiang, Heng-Pin ; Lee, Jia-Jung ; Chiu, Yi-Wen ; Tsai, Jer-Chia ; Hung, Chi-Chih ; Hwang, Shang-Jyh ; Chen, Hung-Chun</creator><creatorcontrib>Chiang, Heng-Pin ; Lee, Jia-Jung ; Chiu, Yi-Wen ; Tsai, Jer-Chia ; Hung, Chi-Chih ; Hwang, Shang-Jyh ; Chen, Hung-Chun</creatorcontrib><description>BACKGROUND Systolic blood pressure (SBP) goal for chronic kidney disease (CKD) patients is ≤140mm Hg. However, the SBP target provides no suggested lower limit, and some studies indicate that a lower SBP target may be harmful. We aimed to investigate the J-shaped relationship between SBP and clinical outcomes in CKD patients and the factors that modify this relationship. METHODS This prospective observational study enrolled 2,144 CKD stage 3-4 patients between November 2002 and May 2009 and followed them until July 2010 or death. Patients included were also enrolled within the Integrated CKD Care Program for Delaying Dialysis in a medical center and its branch hospital. Demographic, clinical, laboratory, and disease variables at baseline and end of observation were measured. RESULTS In diabetic CKD patients, the hazard ratio (HR) at SBP 96-110mm Hg vs. 111-120mm Hg was 2.52 (95% confidence interval (CI) = 1.13-5.58) for cardiovascular outcomes and was 3.14 (95% CI = 1.16-8.49) for renal outcomes. In nondiabetic CKD patients, this J-shaped relationship was not seen. Heavy proteinuria was further found to modify the J-shaped relationship in diabetic CKD patients. The HR for renal outcomes at SBP 96-110mm Hg vs. 111-120mm Hg was 4.07 (95% CI = 1.18-13.99) in diabetic CKD patients with heavy proteinuria vs. 1.72 (95% CI = 0.13-22.5) in those without heavy proteinuria. CONCLUSIONS Diabetic CKD patients have a J-shaped relationship between SBP and cardiovascular or renal outcomes, but nondiabetic CKD patients do not. The optimal SBP range might be narrower in the diabetic CKD patients.</description><identifier>ISSN: 0895-7061</identifier><identifier>EISSN: 1941-7225</identifier><identifier>DOI: 10.1093/ajh/hpu056</identifier><identifier>PMID: 24727359</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Aged ; Antihypertensive Agents - therapeutic use ; Blood pressure ; Blood Pressure - drug effects ; Diabetes ; Disease Progression ; Female ; Humans ; Hypertension ; Hypertension - diagnosis ; Hypertension - drug therapy ; Hypertension - mortality ; Hypertension - physiopathology ; Kidney diseases ; Kidney Failure, Chronic - mortality ; Kidney Failure, Chronic - physiopathology ; Kidney Failure, Chronic - therapy ; Male ; Middle Aged ; Original ; Proportional Hazards Models ; Prospective Studies ; Renal Dialysis ; Renal Insufficiency, Chronic - diagnosis ; Renal Insufficiency, Chronic - mortality ; Renal Insufficiency, Chronic - physiopathology ; Renal Insufficiency, Chronic - therapy ; Risk Factors ; Severity of Illness Index ; Systole ; Taiwan ; Time Factors ; Treatment Outcome</subject><ispartof>American journal of hypertension, 2014-11, Vol.27 (11), p.1396-1407</ispartof><rights>American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2014</rights><rights>American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</rights><rights>American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3</citedby><cites>FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24727359$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chiang, Heng-Pin</creatorcontrib><creatorcontrib>Lee, Jia-Jung</creatorcontrib><creatorcontrib>Chiu, Yi-Wen</creatorcontrib><creatorcontrib>Tsai, Jer-Chia</creatorcontrib><creatorcontrib>Hung, Chi-Chih</creatorcontrib><creatorcontrib>Hwang, Shang-Jyh</creatorcontrib><creatorcontrib>Chen, Hung-Chun</creatorcontrib><title>Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort</title><title>American journal of hypertension</title><addtitle>Am J Hypertens</addtitle><description>BACKGROUND Systolic blood pressure (SBP) goal for chronic kidney disease (CKD) patients is ≤140mm Hg. However, the SBP target provides no suggested lower limit, and some studies indicate that a lower SBP target may be harmful. We aimed to investigate the J-shaped relationship between SBP and clinical outcomes in CKD patients and the factors that modify this relationship. METHODS This prospective observational study enrolled 2,144 CKD stage 3-4 patients between November 2002 and May 2009 and followed them until July 2010 or death. Patients included were also enrolled within the Integrated CKD Care Program for Delaying Dialysis in a medical center and its branch hospital. Demographic, clinical, laboratory, and disease variables at baseline and end of observation were measured. RESULTS In diabetic CKD patients, the hazard ratio (HR) at SBP 96-110mm Hg vs. 111-120mm Hg was 2.52 (95% confidence interval (CI) = 1.13-5.58) for cardiovascular outcomes and was 3.14 (95% CI = 1.16-8.49) for renal outcomes. In nondiabetic CKD patients, this J-shaped relationship was not seen. Heavy proteinuria was further found to modify the J-shaped relationship in diabetic CKD patients. The HR for renal outcomes at SBP 96-110mm Hg vs. 111-120mm Hg was 4.07 (95% CI = 1.18-13.99) in diabetic CKD patients with heavy proteinuria vs. 1.72 (95% CI = 0.13-22.5) in those without heavy proteinuria. CONCLUSIONS Diabetic CKD patients have a J-shaped relationship between SBP and cardiovascular or renal outcomes, but nondiabetic CKD patients do not. The optimal SBP range might be narrower in the diabetic CKD patients.</description><subject>Aged</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Diabetes</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - diagnosis</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - mortality</subject><subject>Hypertension - physiopathology</subject><subject>Kidney diseases</subject><subject>Kidney Failure, Chronic - mortality</subject><subject>Kidney Failure, Chronic - physiopathology</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Proportional Hazards Models</subject><subject>Prospective Studies</subject><subject>Renal Dialysis</subject><subject>Renal Insufficiency, Chronic - diagnosis</subject><subject>Renal Insufficiency, Chronic - mortality</subject><subject>Renal Insufficiency, Chronic - physiopathology</subject><subject>Renal Insufficiency, Chronic - therapy</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Systole</subject><subject>Taiwan</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0895-7061</issn><issn>1941-7225</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kV1rFDEUhoModlu98QdIQLwpjM13Jl4IutZWLLTQeh2SzJlOlt3JmsxU9t8b2bboTa_OxXnOe154EHpDyQdKDD9xq-Fk2M5EqmdoQY2gjWZMPkcL0hrZaKLoATosZUUIEUrRl-iACc00l2aByvWuTGkdA_6yTqnDVxlKmTNgN3b4cp5C2kDBccTXk7sFzBuBl0NOYz34EbsRdvhrLOAK4Cs3RRin8hGf3sUOxgC4z2mDHb5x8bcboTLLNKQ8vUIvercu8Pp-HqGf305vlufNxeXZ9-XniyZIwqZGhJ6ACmA8c741nhAqqfJdH4LQ3nPdtkY56ZhiQijvFaOy10JT6J02MvAj9Gmfu539BrpQ22W3ttscNy7vbHLR_r8Z42Bv050VTHHDVQ14dx-Q068ZymRXac5j7WwZJ4oz3hpdqeM9FXIqJUP_-IES-1eQrYLsXlCF3_7b6RF9MFKB93sgzdungv4Aw2eahw</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Chiang, Heng-Pin</creator><creator>Lee, Jia-Jung</creator><creator>Chiu, Yi-Wen</creator><creator>Tsai, Jer-Chia</creator><creator>Hung, Chi-Chih</creator><creator>Hwang, Shang-Jyh</creator><creator>Chen, Hung-Chun</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>5PM</scope></search><sort><creationdate>20141101</creationdate><title>Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort</title><author>Chiang, Heng-Pin ; Lee, Jia-Jung ; Chiu, Yi-Wen ; Tsai, Jer-Chia ; Hung, Chi-Chih ; Hwang, Shang-Jyh ; Chen, Hung-Chun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Diabetes</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - diagnosis</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - mortality</topic><topic>Hypertension - physiopathology</topic><topic>Kidney diseases</topic><topic>Kidney Failure, Chronic - mortality</topic><topic>Kidney Failure, Chronic - physiopathology</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Proportional Hazards Models</topic><topic>Prospective Studies</topic><topic>Renal Dialysis</topic><topic>Renal Insufficiency, Chronic - diagnosis</topic><topic>Renal Insufficiency, Chronic - mortality</topic><topic>Renal Insufficiency, Chronic - physiopathology</topic><topic>Renal Insufficiency, Chronic - therapy</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Systole</topic><topic>Taiwan</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chiang, Heng-Pin</creatorcontrib><creatorcontrib>Lee, Jia-Jung</creatorcontrib><creatorcontrib>Chiu, Yi-Wen</creatorcontrib><creatorcontrib>Tsai, Jer-Chia</creatorcontrib><creatorcontrib>Hung, Chi-Chih</creatorcontrib><creatorcontrib>Hwang, Shang-Jyh</creatorcontrib><creatorcontrib>Chen, Hung-Chun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chiang, Heng-Pin</au><au>Lee, Jia-Jung</au><au>Chiu, Yi-Wen</au><au>Tsai, Jer-Chia</au><au>Hung, Chi-Chih</au><au>Hwang, Shang-Jyh</au><au>Chen, Hung-Chun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort</atitle><jtitle>American journal of hypertension</jtitle><addtitle>Am J Hypertens</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>27</volume><issue>11</issue><spage>1396</spage><epage>1407</epage><pages>1396-1407</pages><issn>0895-7061</issn><eissn>1941-7225</eissn><abstract>BACKGROUND Systolic blood pressure (SBP) goal for chronic kidney disease (CKD) patients is ≤140mm Hg. However, the SBP target provides no suggested lower limit, and some studies indicate that a lower SBP target may be harmful. We aimed to investigate the J-shaped relationship between SBP and clinical outcomes in CKD patients and the factors that modify this relationship. METHODS This prospective observational study enrolled 2,144 CKD stage 3-4 patients between November 2002 and May 2009 and followed them until July 2010 or death. Patients included were also enrolled within the Integrated CKD Care Program for Delaying Dialysis in a medical center and its branch hospital. Demographic, clinical, laboratory, and disease variables at baseline and end of observation were measured. RESULTS In diabetic CKD patients, the hazard ratio (HR) at SBP 96-110mm Hg vs. 111-120mm Hg was 2.52 (95% confidence interval (CI) = 1.13-5.58) for cardiovascular outcomes and was 3.14 (95% CI = 1.16-8.49) for renal outcomes. In nondiabetic CKD patients, this J-shaped relationship was not seen. Heavy proteinuria was further found to modify the J-shaped relationship in diabetic CKD patients. The HR for renal outcomes at SBP 96-110mm Hg vs. 111-120mm Hg was 4.07 (95% CI = 1.18-13.99) in diabetic CKD patients with heavy proteinuria vs. 1.72 (95% CI = 0.13-22.5) in those without heavy proteinuria. CONCLUSIONS Diabetic CKD patients have a J-shaped relationship between SBP and cardiovascular or renal outcomes, but nondiabetic CKD patients do not. The optimal SBP range might be narrower in the diabetic CKD patients.</abstract><cop>United States</cop><pub>Oxford University Press</pub><pmid>24727359</pmid><doi>10.1093/ajh/hpu056</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0895-7061
ispartof American journal of hypertension, 2014-11, Vol.27 (11), p.1396-1407
issn 0895-7061
1941-7225
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4263936
source Oxford Journals Online
subjects Aged
Antihypertensive Agents - therapeutic use
Blood pressure
Blood Pressure - drug effects
Diabetes
Disease Progression
Female
Humans
Hypertension
Hypertension - diagnosis
Hypertension - drug therapy
Hypertension - mortality
Hypertension - physiopathology
Kidney diseases
Kidney Failure, Chronic - mortality
Kidney Failure, Chronic - physiopathology
Kidney Failure, Chronic - therapy
Male
Middle Aged
Original
Proportional Hazards Models
Prospective Studies
Renal Dialysis
Renal Insufficiency, Chronic - diagnosis
Renal Insufficiency, Chronic - mortality
Renal Insufficiency, Chronic - physiopathology
Renal Insufficiency, Chronic - therapy
Risk Factors
Severity of Illness Index
Systole
Taiwan
Time Factors
Treatment Outcome
title Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T22%3A49%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systolic%20Blood%20Pressure%20and%20Outcomes%20in%20Stage%203-4%20Chronic%20Kidney%20Disease%20Patients:%20Evidence%20from%20a%20Taiwanese%20Cohort&rft.jtitle=American%20journal%20of%20hypertension&rft.au=Chiang,%20Heng-Pin&rft.date=2014-11-01&rft.volume=27&rft.issue=11&rft.spage=1396&rft.epage=1407&rft.pages=1396-1407&rft.issn=0895-7061&rft.eissn=1941-7225&rft_id=info:doi/10.1093/ajh/hpu056&rft_dat=%3Cproquest_pubme%3E2306323897%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2306323897&rft_id=info:pmid/24727359&rft_oup_id=10.1093/ajh/hpu056&rfr_iscdi=true